Form 4 for RCEL AVITA Medical, Inc.

Accepted 2022-12-14 00:00:00 ET · period of report 2022-12-12 · accession 0001209191-22-061281 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-12-14	2022-12-12	RCEL	Crowe Suzanne	Dir	A - Grant	—	+12.6K	21.1K	+149%	—
D	2022-12-14	2022-12-12	RCEL	Crowe Suzanne	Dir	A - Grant	$0.00	+5,395	5,395	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-12-12	A	A	12,589	—	21,051	D	—	—	(F1) Represents an award of Restricted Stock Units ("RSUs"), each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date. (F3) Includes unvested RSUs. (F2) Includes 20,560 of the Issuer's CHESS Depositary Interests ("CDIs"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the "ASX") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of Common Stock and have all the rights and privileges of Common Stock. The Reporting Person's 20,560 CDIs translate into 4,112 of the shares of Common Stock set forth above.
2	Derivative	Stock Options (Right to Buy)	2022-12-12	A	A	5,395	$0.00	5,395	D	$6.95 · — to 2032-12-12	5,395 Common Stock	(F4) These Stock Options vest on the date 12 months following the grant date.